AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2018
Feb 8, 2018
31949_dirs_2018-02-08_4e19984e-23ae-412e-8745-1a0bd76e71f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-02-06
Reporting Person: Ambrogi Michael J. (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-06 | Ordinary Shares | M | 50000 | $0.23 | Acquired | 74087 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-06 | Options to Buy Ordinary Shares | $0.23 | M | 50000 | Disposed | 2019-01-10 | Ordinary Shares (50000) | Direct |
Footnotes
F1: Fully vested and currently exercisable as of the date hereof.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3